Literature DB >> 20437543

Perry syndrome due to the DCTN1 G71R mutation: a distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure.

Victoria Newsway1, Mark Fish, Jonathan D Rohrer, Elisa Majounie, Nigel Williams, Melissa Hack, Jason D Warren, Huw R Morris.   

Abstract

Perry syndrome is a rare form of autosomal dominant Parkinsonism with respiratory failure recently defined as being due to mutations in the DCTN1 gene. We describe a new family carrying a G71R mutation in the DCTN1 gene. The proband displayed a series of distinctive features not previously described in Perry syndrome: a disorder of vertical downward saccades accompanied by progressive midbrain atrophy, predominant nonmotor symptoms responsive to levodopa, distinctive craniocervical levodopa induced dyskinesias, and a good response to high-dose levodopa therapy and respiratory support. The family was initially thought to have autosomal dominant behavioral variant frontotemporal dementia with Parkinsonism. This report expands the clinical definition of this distinctive syndrome. 2009 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20437543      PMCID: PMC4610057          DOI: 10.1002/mds.22950

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD.

Authors:  Christoph Münch; Angela Rosenbohm; Anne-Dorte Sperfeld; Ingo Uttner; Sven Reske; Bernd J Krause; Reinhard Sedlmeier; Thomas Meyer; Clemens O Hanemann; Gabriele Stumm; Albert C Ludolph
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

3.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

4.  Distal spinal and bulbar muscular atrophy caused by dynactin mutation.

Authors:  Imke Puls; Shin J Oh; Charlotte J Sumner; Karen E Wallace; Mary Kay Floeter; Eric A Mann; William R Kennedy; Gwen Wendelschafer-Crabb; Alexander Vortmeyer; Richard Powers; Kimberly Finnegan; Erika L F Holzbaur; Kenneth H Fischbeck; Christy L Ludlow
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

5.  Hereditary mental depression and Parkinsonism with taurine deficiency.

Authors:  T L Perry; P J Bratty; S Hansen; J Kennedy; N Urquhart; C L Dolman
Journal:  Arch Neurol       Date:  1975-02

Review 6.  Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome)--a literature review.

Authors:  Christian Wider; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2007-09-17       Impact factor: 4.891

7.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

8.  Elucidating the genetics and pathology of Perry syndrome.

Authors:  Christian Wider; Justus C Dachsel; Matthew J Farrer; Dennis W Dickson; Yoshio Tsuboi; Zbigniew K Wszolek
Journal:  J Neurol Sci       Date:  2009-09-04       Impact factor: 3.181

9.  Pallidonigral TDP-43 pathology in Perry syndrome.

Authors:  Christian Wider; Dennis W Dickson; A Jon Stoessl; Yoshio Tsuboi; Françoise Chapon; Ludwig Gutmann; Bernard Lechevalier; Donald B Calne; David A Personett; Mary Hulihan; Jennifer Kachergus; Rosa Rademakers; Matthew C Baker; Linda L Grantier; O K Sujith; Laura Brown; Susan Calne; Matthew J Farrer; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2008-08-23       Impact factor: 4.891

10.  DCTN1 mutations in Perry syndrome.

Authors:  Matthew J Farrer; Mary M Hulihan; Jennifer M Kachergus; Justus C Dächsel; A Jon Stoessl; Linda L Grantier; Susan Calne; Donald B Calne; Bernard Lechevalier; Francoise Chapon; Yoshio Tsuboi; Tatsuo Yamada; Ludwig Gutmann; Bülent Elibol; Kailash P Bhatia; Christian Wider; Carles Vilariño-Güell; Owen A Ross; Laura A Brown; Monica Castanedes-Casey; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Nat Genet       Date:  2009-01-11       Impact factor: 38.330

View more
  16 in total

1.  Parkinsonism and frontotemporal dementia: the clinical overlap.

Authors:  Alberto J Espay; Irene Litvan
Journal:  J Mol Neurosci       Date:  2011-09-03       Impact factor: 3.444

Review 2.  Vertical supranuclear gaze palsy in Niemann-Pick type C disease.

Authors:  Ettore Salsano; Chizoba Umeh; Alessandra Rufa; Davide Pareyson; David S Zee
Journal:  Neurol Sci       Date:  2012-07-19       Impact factor: 3.307

Review 3.  DCTN1-related neurodegeneration: Perry syndrome and beyond.

Authors:  Takuya Konno; Owen A Ross; Hélio A G Teive; Jarosław Sławek; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2017-06-12       Impact factor: 4.891

4.  Bi-allelic Variants in DYNC1I2 Cause Syndromic Microcephaly with Intellectual Disability, Cerebral Malformations, and Dysmorphic Facial Features.

Authors:  Muhammad Ansar; Farid Ullah; Sohail A Paracha; Darius J Adams; Abbe Lai; Lynn Pais; Justyna Iwaszkiewicz; Francisca Millan; Muhammad T Sarwar; Zehra Agha; Sayyed Fahim Shah; Azhar Ali Qaisar; Emilie Falconnet; Vincent Zoete; Emmanuelle Ranza; Periklis Makrythanasis; Federico A Santoni; Jawad Ahmed; Nicholas Katsanis; Christopher Walsh; Erica E Davis; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2019-05-09       Impact factor: 11.025

5.  DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes.

Authors:  Paola Caroppo; Isabelle Le Ber; Fabienne Clot; Sophie Rivaud-Péchoux; Agnès Camuzat; Anne De Septenville; Claire Boutoleau-Bretonnière; Vanessa Mourlon; Mathilde Sauvée; Thibaud Lebouvier; Anne-Marie Bonnet; Richard Levy; Martine Vercelletto; Alexis Brice
Journal:  JAMA Neurol       Date:  2014-02       Impact factor: 18.302

6.  Three families with Perry syndrome from distinct parts of the world.

Authors:  Pawel Tacik; Fabienne C Fiesel; Shinsuke Fujioka; Owen A Ross; Felipe Pretelt; Camilo Castañeda Cardona; Alexa Kidd; Michael Hlavac; Anthony Raizis; Michael S Okun; Sharleen Traynor; Audrey J Strongosky; Wolfdieter Springer; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2014-05-13       Impact factor: 4.891

Review 7.  Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician.

Authors:  Una-Marie Sheerin; Henry Houlden; Nicholas W Wood
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

Review 8.  Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders.

Authors:  Sonja W Scholz; Jose Bras
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

Review 9.  Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review.

Authors:  Jarosław Dulski; Catalina Cerquera-Cleves; Lukasz Milanowski; Alexa Kidd; Emilia J Sitek; Audrey Strongosky; Ana María Vanegas Monroy; Dennis W Dickson; Owen A Ross; Jolanta Pentela-Nowicka; Jarosław Sławek; Zbigniew K Wszolek
Journal:  Eur J Neurol       Date:  2021-08-26       Impact factor: 6.288

Review 10.  Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia.

Authors:  Alberto Benussi; Alessandro Padovani; Barbara Borroni
Journal:  Front Aging Neurosci       Date:  2015-09-01       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.